Spiro-oxindole MDM2 antagonists

Details for Australian Patent Application No. 2010319595 (hide)

Owner The Regents of the University of Michigan

Inventors Wang, Shaomeng; Yu, Shanghai; Sun, Wei; Kumar, Sanjeev; Sun, Duxin; Zou, Peng; Zhao, Yujun; McEachern, Donna

Agent Watermark

Pub. Number AU-A-2010319595

PCT Pub. Number WO2011/060049

Priority 61/260,685 12.11.09 US; 61/263,662 23.11.09 US

Filing date 10 November 2010

Wipo publication date 19 May 2011

International Classifications

C07D 487/10 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 35/00 Antineoplastic agents

C07D 491/107 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/10 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

28 June 2012 PCT application entered the National Phase

  PCT publication WO2011/060049 Priority application(s): WO2011/060049

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319601-A novel sensor array configuration for extending useful sensing length of a swept-wavelength interferometry based system

2010319594-Methods for producing polyhydroxyalkanoate copolymer with high medium chain length monomer content